Author:
Wada David A,Law Mark E,Hsi Eric D,DiCaudo David J,Ma Linglei,Lim Megan S,Souza Aieska de,Comfere Nneka I,Weenig Roger H,Macon William R,Erickson Lori A,Özsan Nazan,Ansell Stephen M,Dogan Ahmet,Feldman Andrew L
Publisher
Springer Science and Business Media LLC
Subject
Pathology and Forensic Medicine
Reference24 articles.
1. Paulli M, Berti E, Rosso R, et al. CD30/Ki-1-positive lymphoproliferative disorders of the skin—clinicopathologic correlation and statistical analysis of 86 cases: a multicentric study from the European Organization for Research and Treatment of Cancer Cutaneous Lymphoma Project Group. J Clin Oncol 1995;13:1343–1354.
2. Mason DY, Harris NL, Delsol G, et al. Anaplastic large cell lymphoma, ALK-negative. In: Swerdlow S, Campo E, Harris N, et al. (eds). WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, 4th edn. International Agency for Research on Cancer: Lyon, France, 2008, pp 317–319.
3. Ralfkiaer E, Willemze R, Paulli M, et al. Primary cutaneous CD30-positive T-cell lymphoproliferative disorders. In: Swerdlow S, Campo E, Harris N, et al. (eds). WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, 4 edn. International Agency for Research on Cancer: Lyon, 2008.
4. Bekkenk MW, Geelen FA, van Voorst Vader PC,et al. Primary and secondary cutaneous CD30(+) lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long term follow-up data of 219 patients and guidelines for diagnosis and treatment. Blood 2000;95:3653–3661.
5. Feldman AL, Law M, Remstein ED, et al. Recurrent translocations involving the IRF4 oncogene locus in peripheral T-cell lymphomas. Leukemia 2009;23:574–580.
Cited by
171 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献